Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination
Open Access
- 16 March 2016
- journal article
- Published by The Royal Society in Proceedings Of The Royal Society B-Biological Sciences
- Vol. 283 (1826) , 20160054
Abstract
Herpes zoster arises from reactivation of the varicella–zoster virus (VZV), causing varicella in children. As reactivation occurs when cell-mediated immunity (CMI) declines, and there is evidence that re-exposure to VZV boosts CMI, mass varicella immunization might increase the zoster burden, at least for some decades. Fear of this natural zoster boom is the main reason for the paralysis of varicella immunization in Europe. We apply optimal control to a realistically parametrized age-structured model for VZV transmission and reactivation to investigate whether feasible varicella immunization paths that are optimal in controlling both varicella and zoster exist. We analyse the optimality system numerically focusing on the role of the cost functional, of the relative zoster–varicella cost and of the planning horizon length. We show that optimal programmes will mostly be unfeasible for public health owing to their complex temporal profiles. This complexity is the consequence of the intrinsically antagonistic nature of varicella immunization programmes when aiming to control both varicella and zoster. However, we show that gradually increasing—hence feasible—vaccination schedules can perform better than routine programmes with constant vaccine uptake. Finally, we show the optimal profiles of feasible programmes targeting mitigation of the post-immunization natural zoster boom with priority.Keywords
This publication has 32 references indexed in Scilit:
- Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary ReviewPLOS ONE, 2013
- Perspectives on the Impact of Varicella Immunization on Herpes Zoster. A Model-Based Evaluation from Three European CountriesPLOS ONE, 2013
- Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project dataVaccine, 2013
- Does Monastic Life Predispose to the Risk of Saint Anthony's Fire (Herpes Zoster)?Clinical Infectious Diseases, 2011
- Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in EnglandVaccine, 2011
- The Incidence and Clinical Characteristics of Herpes Zoster Among Children and Adolescents After Implementation of Varicella VaccinationThe Pediatric Infectious Disease Journal, 2009
- Optimal control strategy for prevention of avian influenza pandemicJournal of Theoretical Biology, 2009
- Varicella vaccination in Europe – taking the practical approachBMC Medicine, 2009
- Varicella Prevention in the United States: A Review of Successes and ChallengesPediatrics, 2008
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005